Clinical Trial Update: Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia or Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating a combination chemotherapy regimen in patients with recurrent or refractory leukemia or lymphoma; the study status is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Leukemia, Lymphoma | Phase 2 | Status: COMPLETED